Zeming Lei

Zeming Lei

Auto-generated profile, based on publicly available information

Zeming Lei

Department of Hand Surgery, Central Hospital Affiliated to Shenyang Medical College, Shenyang, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ZLZeming Lei
Zeming Lei
HZHangzhou Zhang
Hangzhou Zhang
EZErlin Zhang
Erlin Zhang
JYJunhua You
Junhua You
XMXiaoxue Ma
Xiaoxue Ma
XBXizhuang Bai
Xizhuang Bai

26 August 2025 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
LYLiangzi Yin
Liangzi Yin
CSChenglin Sun
Chenglin Sun
JZJunjie Zhang
Junjie Zhang
YLYan Li
Yan Li
YWYansheng Wang
Yansheng Wang
ZLZeming Lei
Zeming Lei
Bone homeostasis is dynamically regulated by the balance between osteoclast-mediated bone resorption and osteoblast-driven bone formation. Periprosthetic osteolysis (PPO), a major complication following joint arthroplasty, occurs when excessive bone resorption surpasses formation, leading to implant loosening and failure. Emerging evidence highlights the pivotal roles of the RANKL/RANK/OPG axis, nuclear factor-κB (NF-κB) signaling, and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) cascades in osteoclast differentiation and pathological bone resorption. This review systematically explores the molecular mechanisms by which these pathways regulate osteoclastogenesis and their pathological contributions to PPO. Specifically, we analyze how wear particle-induced inflammation reprograms these signaling networks to exacerbate osteolytic activity. Furthermore, we discuss potential therapeutic strategies targeting these pathways, including pharmacological inhibitors, gene therapy, and dual-target interventions, to restore bone homeostasis. By integrating recent advances in osteoimmunology and translational research, this work provides a comprehensive framework for understanding PPO pathogenesis and developing precision therapies.

1 January 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
XLXingwang Liu
Xingwang Liu
CCChen Chen
Chen Chen
HZHangzhou Zhang
Hangzhou Zhang
ATAng Tian
Ang Tian
JYJunhua You
Junhua You
SCShiyi Chen
Shiyi Chen
Background: Implant-related infection is a major problem postsurgery. As an alternative to a localized antibiotic release system, we used Ag to fabricate Ti–Ag alloys with nanotubular coatings (TiAg-NTs). Ag has excellent antibacterial properties, but its biological toxicity is a concern. Therefore, we performed biological experiments both in vitro and in vivo to evaluate the biocompatibility of TiAg-NTs with different concentrations of Ag (1%, 2%, and 4%). Methods: For in vitro experiments, cytocompatibility, including cell attachment, viability, and proliferation, was tested, and genes and proteins related to osteogenic differentiation were also evaluated. For in vivo assays, the rat femoral condylar insertion model was used, and micro-computed tomography (micro-CT) and histological analysis were conducted to analyze bone formation around implants at 1, 2, and 4 weeks after surgery. Results: Both in vitro and in vivo results indicate that Ti2%Ag-NT showed comparable cytocompatibility with commercially pure Ti (cp-Ti), and it could achieve good osseointegration with the surrounding bone tissue. Conclusion: We thus believe that Ti2%Ag-NT is a potential biomaterial for orthopedics.

19 October 2023 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
XWXinzhu Wang
Xinzhu Wang
YWYansheng Wang
Yansheng Wang
NYNing Yu
Ning Yu
HXHui Xu
Hui Xu
ZLZeming Lei
Zeming Lei